Story perspectives

Medtronic Buys SPR for $650M, Beats Q4 Forecast

6/4/2026

Summary

Medtronic Acquires

Medtronic announced a $650 million cash acquisition of SPR Therapeutics, adding FDA-cleared temporary peripheral nerve stimulation technology for non-opioid pain relief.
The company posted fiscal Q4 revenue of $9.81 billion versus $9.61 billion consensus and adjusted EPS of $1.55, prompting a 5%–6% share rise to $82.65 by 2026-06-04.
Medtronic forecast fiscal 2027 EPS of $5.90–$6.00, organic revenue growth of 6.75%–7.25%, and raised its quarterly dividend to $0.72 per share.

Summary

Medtronic Announces Dividend

Medtronic announced a quarterly cash dividend of 71 cents per share, setting the ex-dividend date for late June 2026 and the payment for July 2026.
The trailing-12-month payout of $2.84 yields 3.83% at the current price, requiring about $155,833 (?2,113 shares) to generate $500 per month.
Earning $100 per month needs roughly $31,123 (?422 shares), with the dividend yield changing as the stock price moves.

1 of 2

Medtronic Acquires

Medtronic announced a $650 million cash acquisition of SPR Therapeutics, adding FDA-cleared temporary peripheral nerve stimulation technology for non-opioid pain relief.
The company posted fiscal Q4 revenue of $9.81 billion versus $9.61 billion consensus and adjusted EPS of $1.55, prompting a 5%–6% share rise to $82.65 by 2026-06-04.
Medtronic forecast fiscal 2027 EPS of $5.90–$6.00, organic revenue growth of 6.75%–7.25%, and raised its quarterly dividend to $0.72 per share.

1 / 2